Cardiac Rhythm Management

Latest News for 2017

shadow-div-content

Abbott Announces U.S. Approval for its Assurity MRI™ Pacemaker, the World's Smallest, Longest-Lasting Wireless MRI-Compatible Pacemaker

Read more...

Armetheon Announces European Medicines Agency's Support for 1000 Patient Single Phase 3 Study prior to MAA Filing for its Novel Oral Anticoagulant Tecarfarin

Read more...

Cardiome Receives Notice of Compliance from Health Canada for its BRINAVESS NDS

Read more...

Daiichi Sankyo, Inc. Announces New Analyses of Once-Daily SAVAYSA® (edoxaban) in Patients with Non-valvular Atrial Fibrillation to be Presented at the ACC 66th Annual Scientific Session

Read more...

AliveCor Unveils First AI-Enabled Platform for Doctors to Improve Stroke Prevention Through Early Atrial Fibrillation Detection

Read more...

Armetheon announces issuance of a new U.S. patent for its Phase 2 clinical stage novel oral anti-arrhythmic budiodarone

Read more...

Daiichi Sankyo, Inc. Initiates ENTRUST-AF PCI Study Investigating Once-Daily SAVAYSA® (edoxaban) in Patients with Atrial Fibrillation Undergoing Percutaneous Coronary Intervention with Stenting

Read more...

Real-World Data from Boehringer Ingelheim Show Lower Risk of Stroke and Major Bleeding for Pradaxa® (dabigatran etexilate mesylate) Compared to Warfarin

Read more...

More Articles...

Advertisement